{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:53:45Z","timestamp":1761742425094,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.jinf.2004.05.014","type":"journal-article","created":{"date-parts":[[2004,8,17]],"date-time":"2004-08-17T09:09:01Z","timestamp":1092733741000},"page":"210-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"K.","family":"Roos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Baz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rangaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2004.05.014_BIB1","series-title":"Principles and practices of infectious disease","first-page":"585","author":"Gwaltney","year":"1990"},{"key":"10.1016\/j.jinf.2004.05.014_BIB2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00019048-199705000-00002","article-title":"IDCP guidelines: management of upper respiratory tract infections","volume":"6","author":"Bartlett","year":"1997","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.jinf.2004.05.014_BIB3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF02599141","article-title":"Current diagnosis and management of sinusitis","volume":"9","author":"Willett","year":"1994","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jinf.2004.05.014_BIB4","first-page":"1","article-title":"Antimicrobial treatment guidelines for acute bacterial rhinosinusitis","volume":"123","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jinf.2004.05.014_BIB5","first-page":"2","article-title":"Medical management of acute bacterial sinusitis. Recommendations of a clinical advisory committee on pediatric and adult sinusitis","volume":"182","author":"Brooks","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jinf.2004.05.014_BIB6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1179\/joc.1999.11.Supplement-2.35","article-title":"Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?","volume":"11","author":"Baquero","year":"1999","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2004.05.014_BIB7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jac\/45.4.457","article-title":"Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997\u20131998","volume":"45","author":"Sahm","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2004.05.014_BIB8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/45.2.191","article-title":"The Alexander Project 1996\u20131997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections","volume":"45","author":"Felmingham","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2004.05.014_BIB9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.43.8.1901","article-title":"Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study","volume":"43","author":"Jacobs","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2004.05.014_BIB10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s100960050337","article-title":"Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens","volume":"18","author":"Cizman","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.014_BIB11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jac\/46.5.767","article-title":"Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and \u03b2-lactam consumption in Spain (1979\u20131997)","volume":"46","author":"Granizo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2004.05.014_BIB12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2004.05.014_BIB13","unstructured":"Felmingham D, Harding I. Telithromycin is highly active against clinical isolates of Streptococcus pneumoniae collected in the PROTEKT study, irrespective of penicillin, macrolide or fluoroquinolone resistance [Abstract]. 11th European Congress of Clinical Microbiology and Infectious Diseases; 1\u20134 April 2001, Istanbul, Turkey."},{"key":"10.1016\/j.jinf.2004.05.014_BIB14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1469-0691.2001.0070s3002.x","article-title":"Microbiological profile of telithromycin, the first ketolide antimicrobial","volume":"7","author":"Felmingham","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2004.05.014_BIB15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00003495-200161060-00016","article-title":"Telithromycin","volume":"61","author":"Barman Balfour","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jinf.2004.05.014_BIB16","series-title":"Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, 16\u201319 December 2001; Chicago, USA","article-title":"Five-day therapy with the new ketolide telithromycin is as effective as standard 10-day comparators in the treatment of AMS [Abstract 909]","author":"Roos","year":"2001"},{"key":"10.1016\/j.jinf.2004.05.014_BIB17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/194589240301700610","article-title":"A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis","volume":"17","author":"Buchanan","year":"2003","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jinf.2004.05.014_BIB18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000057670","article-title":"Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis","volume":"48","author":"Roos","year":"2002","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jinf.2004.05.014_BIB19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/014556130308200812","article-title":"Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin\/clavulanic acid for 10 days in acute maxillary sinusitis","volume":"82","author":"Luterman","year":"2003","journal-title":"Ear Nose Throat J"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2004.05.014_BIB20","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/clind\/15.Supplement_1.S62","article-title":"Evaluation of new anti-infective drugs for the treatment of respiratory tract infections","volume":"15","author":"Chow","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.014_BIB21","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS), Performance standards for antimicrobial disk susceptibility tests; approved standard., 7th ed. M2-A7. Wayne, PA: NCCLS; 2000."},{"year":"2001","series-title":"Performance standards for antimicrobial disk susceptibility tests; eleventh informational M100-S11","key":"10.1016\/j.jinf.2004.05.014_BIB22"},{"key":"10.1016\/j.jinf.2004.05.014_BIB23","first-page":"69","article-title":"Adult rhinosinusitis: diagnosis and management","volume":"63","author":"Osguthorpe","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jinf.2004.05.014_BIB24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9343(92)90232-Z","article-title":"Clinical comparison of cefuroxime axetil and amoxicillin\u2013clavulanate in the treatment of patients with acute maxillary sinusitis","volume":"93","author":"Camacho","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2004.05.014_BIB25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archfami.2.8.837","article-title":"Multicenter comparison of clarithromycin and amoxicillin in the treatment of acute maxillary sinusitis","volume":"2","author":"Calhoun","year":"1993","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.jinf.2004.05.014_BIB26","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/AAC.41.7.1517","article-title":"Comparative effectiveness and safety of cefdinir and amoxicillin\u2013clavulanate in treatment of acute community-acquired bacterial sinusitis","volume":"41","author":"Gwaltney","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2004.05.014_BIB27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/00365549509019014","article-title":"Treatment of acute maxillary sinusitis\u2014comparing cefpodoxime proxetil with amoxicillin","volume":"27","author":"Von Sydow","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.014_BIB28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/000348949910800408","article-title":"Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group","volume":"108","author":"Clifford","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jinf.2004.05.014_BIB29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0149-2918(00)80019-3","article-title":"Comparison of cefuroxime axetil and amoxicillin\u2013clavulanate in the treatment of acute bacterial sinusitis","volume":"21","author":"Henry","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.jinf.2004.05.014_BIB30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/030006059802600602","article-title":"Efficacy and safety of oral levofloxacin compared with clanthromycin in the treatment of acute sinusitis in adults: a multicenter, double-blind, randomized study","volume":"26","author":"Lasko","year":"1998","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jinf.2004.05.014_BIB31","first-page":"3","article-title":"Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis","volume":"28","author":"Johnson","year":"1999","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.jinf.2004.05.014_BIB32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/rmed.1999.0769","article-title":"A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults","volume":"94","author":"Siegert","year":"2000","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2004.05.014_BIB33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/BF01975841","article-title":"Azithromycin concentrations in sinus fluid and mucosa after oral administration","volume":"10","author":"Karma","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.014_BIB34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/47.2.129","article-title":"Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy","volume":"47","author":"Dagan","year":"2001","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445304000970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445304000970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:27:04Z","timestamp":1758986824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445304000970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0163445304000970"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2004.05.014","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2004.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}